Cyclacel Pharmaceuticals, Inc. CYCCP 深 滬
等待開盤 07-31 09:30:00 美东时间
5.05
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.05
- 總市值 169.33万
- 52周最高 16.0999
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.39
- 委 比 0.00%
- 總股本 33.53万
- 歷史最高 21.30
- 量 比 0
- 振 幅 0.00%
- 歷史最低 -4.389
- 每 手 1
- 風險率 0.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
<p>Bio Green Med Solution, Inc. (BGMS) has entered into a Business Combination Agreement (BCA) with Future NRG Sdn. Bhd. (Future NRG) for an all-stock share exchange transaction. The merger aims to create a next-generation environmental platform by combining essential safety and environmental services, focusing on regulatory-driven industries. The combined company will integrate niche sectors of fire safety and green waste treatment, providing a ...
06-04 20:10
Cyclacel Pharmaceuticals Q1 EPS $(0.04) Up From $(11.52) YoY, Sales $778.000K
Cyclacel Pharmaceuticals (NASDAQ:BGMS) reported quarterly losses of $(0.04) per share. This is a 99.65 percent increase over losses of $(11.52) per share from the same period last year. The company reported $778.000
05-15 04:32
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Aterian, Inc. announced the sale of its e-commerce brand portfolio, including Mueller Living, PurSteam, and others, to Trademark Global for $18 million, subject to adjustments. The deal requires shareholder approval and is expected to close in Q2 2026, with proceeds distributed to shareholders in Q3. Aterian also secured a $7 million strategic investment from David Lazar, who will become CEO following the transaction. Lazar has waived rights to a...
04-28 12:00
Bio Green Med Solution’s Strategic Shift and Q3 Results
Cyclacel Pharmaceuticals ( ($BGMS) ) has released its Q3 earnings. Here is a br...
2025-11-14 12:46
Cyclacel Pharmaceuticals: Recent Acquisition Completed
An update from Cyclacel Pharmaceuticals ( ($CYCC) ) is now available. On Septem...
2025-09-12 18:28
Cyclacel Pharmaceuticals Approves Key Shareholder Proposals
Cyclacel Pharmaceuticals ( ($CYCC) ) has provided an update. On September 4, 20...
2025-09-06 00:18
Cyclacel Pharmaceuticals Enters Warrant Exchange Agreement
Cyclacel Pharmaceuticals ( ($CYCC) ) has provided an update. On September 4, 20...
2025-09-05 04:40
Cyclacel Pharmaceuticals Exchanges Series C Warrants For 559,395 Common Shares In Agreement With Accredited Investors
On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the "Exchange Agreement") with certain accredited investors (the "Holders") of existing Series C common
2025-09-05 04:03
